Inotiv, Inc. (FRA:BS50)
Germany flag Germany · Delayed Price · Currency is EUR
0.735
-0.005 (-0.68%)
At close: Dec 4, 2025

Inotiv Company Description

Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally.

It operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS).

The DMS segment manufactures scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the company’s BASi product line.

The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts.

The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021.

Inotiv, Inc. was incorporated in 1974 and is headquartered in West Lafayette, Indiana.

Inotiv, Inc.
Country United States
Founded 1974
Industry Commercial Physical and Biological Research
Employees 2,075
CEO Robert Leasure

Contact Details

Address:
2701 Kent Avenue
West Lafayette, Indiana 47906
United States
Phone 765 463 4527
Website inotiv.com

Stock Details

Ticker Symbol BS50
Exchange Frankfurt Stock Exchange
Fiscal Year October - September
Reporting Currency USD
SIC Code 8731

Key Executives

Name Position
Robert Leasure Chief Executive Officer
Beth Taylor Chief Financial Officer